Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00534781 · ClinicalTrials.gov registry record · Phase 4
Achilles Tendinosis Study; Comparison of Radiofrequency to Surgical MicroDebridement
A Phase 4 study of Achilles Pain and Achilles Tendinosis, sponsored by ArthroCare Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 2
- Study locations
NCT00534781 is a Phase 4 study of Achilles Pain and Achilles Tendinosis that has completed, run by ArthroCare Corporation. The registered enrollment target is 60 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT00534781, a Phase 4 study of Achilles Pain and Achilles Tendinosis, has completed, sponsored by ArthroCare Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a research study to evaluate the outcomes after the study procedure for pain and discomfort in the heel caused from an injury in the Achilles tendon which is located on the back of the foot (commonly called "Achilles tendinitis"-Achilles tendinosis) that has not gotten better with medicine and/or other therapy. Researchers want to see if using the study device changes outcomes for 1 year after the study procedure.
Conditions Studied
Interventions
- DEVICE plasma microdebrider
- PROCEDURE Mechanical Surgical Debridement
Study Locations (2)
Maryland
- Greater Chesapeake Orthopaedic Associates - Baltimore
Ohio
- Orthopaedic Foot and Ankle Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-09 |
| Est. Completion | 2010-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00534781
The ClinicalTrials.gov registry entry for NCT00534781 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ArthroCare Corporation, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Achilles Pain appearing as the primary indexed condition, and to 2 interventions - of which plasma microdebrider is the first listed.
NCT00534781 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Ohio.
Frequently Asked Questions
What is clinical trial NCT00534781 about?
NCT00534781 is a clinical study titled "Achilles Tendinosis Study; Comparison of Radiofrequency to Surgical MicroDebridement". This is a research study to evaluate the outcomes after the study procedure for pain and discomfort in the heel caused from an injury in the Achilles tendon which is located on the back of the foot (commonly called "Achilles tendinitis"-Achilles tendinosis) that has not gotten better with medicine a...
What is the current status of trial NCT00534781?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2007-09. Estimated completion is 2010-09.
What conditions does trial NCT00534781 study?
This clinical trial studies the following conditions: Achilles Pain, Achilles Tendinosis, Heel Pain.
What interventions are being tested in trial NCT00534781?
The interventions under investigation include: plasma microdebrider (DEVICE), Mechanical Surgical Debridement (PROCEDURE).
Who is sponsoring clinical trial NCT00534781?
This trial is sponsored by ArthroCare Corporation, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00534781 being conducted?
This trial has 2 study locations across Maryland, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.